FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3186179908> ?p ?o ?g. }

• W3186179908 endingPage "628" @default.
• W3186179908 startingPage "622" @default.
• W3186179908 abstract "With a vaccine effectiveness of 95% for preventing coronavirus disease 2019 (COVID-19), Pfizer-BioNTech BNT162b2 (BNT162b2) was the first vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to be approved. However, immunosuppressive therapy was an exclusion criterion in the phase 3 trial that led to approval. Thus, extrapolation of the trial results to patients with rheumatic diseases treated with immunosuppressive drugs warrants caution.Patients with systemic lupus erythematosus (SLE; n = 61) and rheumatoid arthritis (RA; n = 73) were included from the COPANARD (Corona Pandemic Autoimmune Rheumatic Disease) cohort, followed since the beginning of the COVID-19 pandemic. Patients received the BNT162b2 vaccine between December 2020 and April 2021. All patients had total antibodies against SARS-CoV-2 measured before vaccination and 1 week after the second vaccination (VITROS Immunodiagnostic Products).Of 134 patients (median age, 70 years), 77% were able to mount a detectable serological response to the vaccine. Among patients treated with rituximab, only 24% had detectable anti-SARS-CoV-2 antibodies in their serum after vaccination. The time since the last rituximab treatment did not seem to influence the vaccine response. No significant difference was observed between patients with RA or SLE when adjusting for treatment, and no correlation between antibody levels and age was detected (r = -0.12; P = 0.18).Antibody measurements against SARS-CoV-2 in patients with RA and SLE after two doses of the BNT162b2 vaccine demonstrated that 23% of patients could not mount a detectable serological response to the vaccine. B cell-depleting therapy (BCDT) is of specific concern, and our findings call for particular attention to the patients receiving BCDT." @default.
• W3186179908 created "2021-08-02" @default.
• W3186179908 creator A5001138548 @default.
• W3186179908 creator A5006938075 @default.
• W3186179908 creator A5007550326 @default.
• W3186179908 creator A5014263716 @default.
• W3186179908 creator A5014440706 @default.
• W3186179908 creator A5043611222 @default.
• W3186179908 creator A5054722146 @default.
• W3186179908 creator A5055689909 @default.
• W3186179908 creator A5060535048 @default.
• W3186179908 creator A5074394409 @default.
• W3186179908 creator A5089030029 @default.
• W3186179908 date "2021-07-17" @default.
• W3186179908 modified "2023-10-06" @default.
• W3186179908 title "Impaired Antibody Response to the BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine in Patients With Systemic Lupus Erythematosus and Rheumatoid Arthritis" @default.
• W3186179908 cites W1513110336 @default.
• W3186179908 cites W2140073887 @default.
• W3186179908 cites W2792992921 @default.
• W3186179908 cites W2967124351 @default.
• W3186179908 cites W2970638348 @default.
• W3186179908 cites W2972635716 @default.
• W3186179908 cites W3024016727 @default.
• W3186179908 cites W3093367571 @default.
• W3186179908 cites W3111255098 @default.
• W3186179908 cites W3122628681 @default.
• W3186179908 cites W3124530866 @default.
• W3186179908 cites W3128017291 @default.
• W3186179908 cites W3133972824 @default.
• W3186179908 cites W3137814380 @default.
• W3186179908 cites W3139115512 @default.
• W3186179908 cites W3139490202 @default.
• W3186179908 cites W3139524064 @default.
• W3186179908 cites W3146894320 @default.
• W3186179908 cites W3164059037 @default.
• W3186179908 doi "https://doi.org/10.1002/acr2.11299" @default.
• W3186179908 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8426741" @default.
• W3186179908 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34273260" @default.
• W3186179908 hasPublicationYear "2021" @default.
• W3186179908 type Work @default.
• W3186179908 sameAs 3186179908 @default.
• W3186179908 citedByCount "63" @default.
• W3186179908 countsByYear W31861799082021 @default.
• W3186179908 countsByYear W31861799082022 @default.
• W3186179908 countsByYear W31861799082023 @default.
• W3186179908 crossrefType "journal-article" @default.
• W3186179908 hasAuthorship W3186179908A5001138548 @default.
• W3186179908 hasAuthorship W3186179908A5006938075 @default.
• W3186179908 hasAuthorship W3186179908A5007550326 @default.
• W3186179908 hasAuthorship W3186179908A5014263716 @default.
• W3186179908 hasAuthorship W3186179908A5014440706 @default.
• W3186179908 hasAuthorship W3186179908A5043611222 @default.
• W3186179908 hasAuthorship W3186179908A5054722146 @default.
• W3186179908 hasAuthorship W3186179908A5055689909 @default.
• W3186179908 hasAuthorship W3186179908A5060535048 @default.
• W3186179908 hasAuthorship W3186179908A5074394409 @default.
• W3186179908 hasAuthorship W3186179908A5089030029 @default.
• W3186179908 hasBestOaLocation W31861799081 @default.
• W3186179908 hasConcept C126322002 @default.
• W3186179908 hasConcept C159654299 @default.
• W3186179908 hasConcept C198451711 @default.
• W3186179908 hasConcept C203014093 @default.
• W3186179908 hasConcept C22070199 @default.
• W3186179908 hasConcept C2777575956 @default.
• W3186179908 hasConcept C2779134260 @default.
• W3186179908 hasConcept C2780653079 @default.
• W3186179908 hasConcept C3008058167 @default.
• W3186179908 hasConcept C45189115 @default.
• W3186179908 hasConcept C524204448 @default.
• W3186179908 hasConcept C71924100 @default.
• W3186179908 hasConcept C89623803 @default.
• W3186179908 hasConceptScore W3186179908C126322002 @default.
• W3186179908 hasConceptScore W3186179908C159654299 @default.
• W3186179908 hasConceptScore W3186179908C198451711 @default.
• W3186179908 hasConceptScore W3186179908C203014093 @default.
• W3186179908 hasConceptScore W3186179908C22070199 @default.
• W3186179908 hasConceptScore W3186179908C2777575956 @default.
• W3186179908 hasConceptScore W3186179908C2779134260 @default.
• W3186179908 hasConceptScore W3186179908C2780653079 @default.
• W3186179908 hasConceptScore W3186179908C3008058167 @default.
• W3186179908 hasConceptScore W3186179908C45189115 @default.
• W3186179908 hasConceptScore W3186179908C524204448 @default.
• W3186179908 hasConceptScore W3186179908C71924100 @default.
• W3186179908 hasConceptScore W3186179908C89623803 @default.
• W3186179908 hasFunder F4320310460 @default.
• W3186179908 hasIssue "9" @default.
• W3186179908 hasLocation W31861799081 @default.
• W3186179908 hasLocation W31861799082 @default.
• W3186179908 hasLocation W31861799083 @default.
• W3186179908 hasLocation W31861799084 @default.
• W3186179908 hasOpenAccess W3186179908 @default.
• W3186179908 hasPrimaryLocation W31861799081 @default.
• W3186179908 hasRelatedWork W2056867162 @default.
• W3186179908 hasRelatedWork W2091629131 @default.
• W3186179908 hasRelatedWork W2156283049 @default.
• W3186179908 hasRelatedWork W2316954211 @default.
• W3186179908 hasRelatedWork W2761967325 @default.
• W3186179908 hasRelatedWork W2801221612 @default.

• next